Study of new lung-check biomarkers in older adults
Part of Cancer, Lungs & breathing clinical trials.
This study looks at new blood or test “biomarkers” to understand how well targeted lung health checks work. You join if you’re already attending the NHS lung health check program and can consent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You attended one or more visits in the NCL NHS TLHC lung health check program
- You are between 55 and 74 years old
- You are able to understand the study and sign a written consent form
- You do not decline participation in the ALPINE study
- A clinician does not decide you are not suitable for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a new test can better identify early lung cancer in people who are being watched for an incidental lung nodule. It may help doctors decide which nodules need closer follow-up or treatment.
This study looks for early signs of lung cancer in people at higher risk. It tests blood and imaging to find markers that might help detect lung cancer sooner.
This study tests whether combining low-dose chest CT scans with blood “biomarker” tests can help find lung cancer earlier in people at higher risk. You may be asked to have scans and blood tests and then attend follow-up visits over time.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This study is a lung health check pilot to find lung cancer early in people who are at higher risk because of their age and smoking history. You will get a free, low-dose CT scan to check for any signs of lung cancer.
This study is testing a new blood test that looks for DNA from lung cancer cells in your blood. It aims to see if the test can find lung cancer early, even before symptoms start.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.